greeksoup/ stock research
Stock research / United States / AQST / Planned sales

Aquestive Therapeutics, Inc. planned insider sales

In the last twelve months insiders at Aquestive Therapeutics, Inc. filed 8 Form 144 notices of planned sales, 220,107 shares worth $1.0 million at the time of filing, from 4 sellers. The latest, filed 15 September 2026: Daniel Barber (director, officer), 50,000 shares worth $244,000, planned for around 15 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
15 September 2026Daniel BarberDirector, Officer50,000$244,00015 September 202650,000 shares from 15 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
9 September 2026Sherry M. KorczynskiOfficer8,750$45,5889 September 20268,750 shares from 9 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
17 August 2026Daniel BarberOfficer25,000$106,25017 August 202625,000 shares from 17 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
15 July 2026Daniel BarberOfficer25,000$101,00015 July 202625,000 shares from 15 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
23 June 2026Julie KropDirector25,000$118,00023 June 202625,000 shares from 23 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
15 June 2026Daniel BarberOfficer25,000$104,25015 June 202625,000 shares from 15 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
15 May 2026Daniel BarberOfficer8,257$39,05615 May 20268,257 shares from 15 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
17 November 2025Carl N. KrausAffiliate53,100$286,20917 November 2025No matching Form 4 saleJ.P. Morgan Securities LLCRSU VestingForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?